Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Utibron Neohaler

indacaterol-glycopyrrolate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Utibron Neohaler POWDER, INHALATION 27.5 mcg/15.6 mcg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

indacaterol-glycopyrrolate (Utibron Neohaler)

  • 27.5 mcg/15.6 mcg ONE capsule inhalation BID

albuterol-ipratropium (DuoNeb)

  • 2.5 mg-0.5 mg/3 mL inhalation solution ONE vial (2.5 mg-0.5 mg) every 6 hours

Reviewed: 24 January 2017

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved